Impact Factor
2.90
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
2.04
196 total citations
h5-index
20
h5 depth signal
Cited share
55.6%
55 of 99
Total citations
196
Citation footprint
Metric signal
2.29
External metric anchor
Self-citation
0.0%
0 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
France
111
China
59
United States
36
Italy
33
Iran
27
Citing Fields of Research
Hematology
149
Immunology
89
Lymphomas
48
Stem Cell Biology
40
Immunotherapy
23
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
484
Articles tracked across the journal lifetime
Indexed publication set
99
55 cited publications
Last 12 months
62
5.6 publications/month
Open access share
21.0%
13 OA publications in the last year
Leading citing country
France
111 citing publications
Leading citing field
Hematology
149 citing publications
Latest tracked publication
29 September 2026
10 recent records available
Coverage & Indexing History
v64n1, March 2016-
v64n1, March 2016-
Research Focus & Classification
Indexed Subjects
Hematology
Immunology
Lymphomas
Transplantation
Broad Categories
Hematology
MeSH Descriptors
Translational Research, Biomedical.
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.1016/j.retram.2026.103613
Open DOI
Synthesis, Evaluation, and Effect of Anti-CD38 Single-chain Immunotoxin on HL-60 acute myeloid Leukemia cell Line
02
03
DOI 10.1016/j.retram.2026.103607
Open DOI
Editorial board
04
DOI 10.1016/j.retram.2026.103612
Open DOI
Painful acrocyanosis as the predominant vascular feature of early anti-Scl-70 positive systemic sclerosis
05
DOI 10.1016/j.retram.2026.103611
Open DOI
Standardized reporting of mononuclear cell apheresis collections: a systematic review and expert recommendations
06
DOI 10.1016/j.retram.2026.103610
Open DOI
Academic manufacturing of anti-CD19 CAR-T cells from a leukapheresis with a high proportion of acute myeloid leukaemia blasts
07
DOI 10.1016/j.retram.2026.103606
Open DOI
Clinical translation of mRNA-based cancer vaccines for solid tumors
08
DOI 10.1016/j.retram.2026.103605
Open DOI
Impact of bone marrow fibrosis on disease characteristics and outcomes in newly diagnosed multiple myeloma patients
09
DOI 10.1016/j.retram.2026.103604
Open DOI
Harnessing dendritic cells (DCs) for melanoma immunotherapy: From basic biology to clinical strategies
10
DOI 10.1016/j.retram.2026.103603
Open DOI